Opinion: New proposal aims at better funded state and local pensions

In an earlier study, my colleague JP Aubry identified the importance of “legacy debt” in public pension plans. This debt

Read more

Fuel cell-powered truck maker Hyzon’s stock suffers record plunge after accounting questions raise delisting fears

Shares of Hyzon Motors Inc. were suffering a record plunge toward a record low Friday, after the maker of fuel

Read more

Opinion: Agricultural plastic is just as harmful as ocean plastic

The first UN Ocean Conference in five years ended recently in Lisbon, Portugal, with Secretary-General António Guterres calling for a

Read more

For small businesses, rising rates, lower optimism—7 things to do to survive.

Small-business owners are faring OK financially right now, but their worries about the future are mounting, according to a new

Read more

Inflation is hitting small businesses hardest in these cities and states

Consumers are spending more on goods and services, but they aren’t the only ones feeling a pinch. Small-business owners are

Read more

VCs target AI accounting startups as companies look to control spending in uncertain economy

Artificial intelligence startup investors are turning their focus to accounting software, a traditionally subdued corner of business technology, as companies

Read more

Better ways your small business can spend and save

This article is reprinted by permission from NerdWallet. When you’re running a small business with tight margins, every transaction counts.

Read more

Senators set to propose sector-friendly crypto rules that promote financial innovation

A pair of US senators were set to propose legislation that would create special exemptions to federal law for some

Read more

Here’s the little-known reason why Cathie Wood’s ARK Innovation ETF is having such a bad year

By now almost everyone knows that ARK Innovation ETF ARKK, -5.41% is having a very bad year. But poor stock

Read more

Drug companies are making an accounting change after the SEC cracked down on Biogen

Reporters and analysts covering first-quarter earnings from drug companies may have noticed a change in how they account for upfront

Read more